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Summary
Study objective: Our study investigates nutritional status, resting energy expendi-
ture (REE) and physical performance in elderly patients with stable COPD to identify
any early conditions of hypermetabolism, malnutrition and sarcopenia.
Methods: Eighty-six males (40 stable COPD and 46 healthy subjects) over 65 years
old were studied. All subjects underwent spirometry, blood gas analysis and a 6-min
walking test (6MWT). Fat-free mass (FFM) and appendicular skeletal muscle mass
(ASMM) were measured by dual energy X-ray absorptiometry (DEXA). REE was
measured by indirect calorimetry.
Results: COPD patients had a lower FFM both expressed in kilograms and after
correction for height squared. The prevalence of sarcopenia was higher for COPD
subjects (38% vs 31%). REE, both in absolute values and adjusted for FFM was
significantly higher in COPD patients. Hypermetabolism was found in 60% of COPD
cases and 13.7% (Po0.01) of healthy subjects. No relationship was found in COPD
patients between the measured/predicted REE ratio (REEm/REEp) and FEV1. In the
hypermetabolic COPD subgroup, the REEm/REEp ratio correlated with 6MWT.
Conclusions: Elderly patients with stable COPD develop an increased REE. This
hypermetabolism seems to be independent of the severity of the pulmonary
obstruction and to influence the patient’s physical performance.
& 2006 Elsevier Ltd. All rights reserved.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a
debilitating condition often associated with physi-
cal impairment and worse quality of life, particu-
larly in old age.1,2
A poor nutritional status is common among
individuals suffering from COPD and is an indepen-
dent predictor of mortality and increased morbid-
ity.3 This is supported by the energy imbalance due
to a low dietary intake4 and a higher resting energy
expenditure (REE).5 This hypermetabolic state is
determined by the chronic inflammatory condition6
and the effort that goes into breathing.7
Previous studies mainly investigated the nutri-
tional status in COPD patients over a wide age
range8,9 and consequently did not consider the
possible effects of a longer-standing disease on REE
and body composition of elderly COPD subjects.
In the elderly, the relationship between nutri-
tional status and COPD is more complex because
malnutrition associated with the illness overlaps
the physiological decline of lean and muscle mass,
called sarcopenia, typical of aging.10 COPD exacer-
bates this muscle mass wasting, which affects both
peripheral and respiratory muscle performance,
leading to a reduction in ventilation and physical
exercise.11 The reduction in fat-free mass (FFM)
and muscle mass in these older patients may be
balanced be an increase in their metabolic activity
to sustain the greater respiratory work. It is
therefore feasible for hypermetabolism to affect
older COPD patients more than younger ones.
Severe malnutrition, as well as underweight status
and low visceral proteins, have been demonstrated in
elderly COPD patients in advanced stages of the
disease,12 often in association with disability. It is
hard to say, however, whether the energy imbalance
already exists in the intermediate stages of the
condition and whether it influences nutritional status,
respiratory function and physical performance.
The aim of our study was to investigate nutritional
status, REE and physical performance in a sample of
elderly patients with stable COPD who were normal-
weight or overweight according to the WHO criteria13
to identify any early hypermetabolism, malnutrition
and sarcopenia and their possible relationship with
physical and pulmonary performance.
Methods
Study subjects
This survey was performed at the Geriatric Depart-
ment of Padua University on 86 males over 65 years
of age. Forty subjects had COPD diagnosed on the
basis of a respiratory functional impairment mea-
sured according to the European Respiratory
Society criteria.14 Only patients with COPD in a
stable clinical condition were considered. Patients
with fever, worsening respiratory symptoms, leu-
kocytosis, changes in medication in the previous 30
days, or hospital admissions in the previous 6 weeks
were considered clinically unstable and excluded.
Subjects with cognitive or physical impairments
severe enough to prevent the performance of
pulmonary function tests were also ruled out. COPD
patients meeting the inclusion and exclusion
criteria were recruited consecutively from among
the outpatients at the Respiratory Pathophysiology
Department in Padua during regular check-ups.
Forty-six healthy elderly subjects were evaluated
as a control group, recruited on a voluntary basis
from elderly people coming to the Department of
Geriatrics for a check-up. Their healthy condition
was established from their clinical history, clinical
examination and normal biochemical test results.
For all subjects, the exclusion criteria were:
severe underweight condition (BMIo18.5 kg/m2) or
obesity (BMI430 kg/m2); acute disease, liver, heart
or kidney failure, endocrine disease, cancer and
inflammatory conditions. The use of drugs (oral or
systemic corticosteroids, theophylline, hormones,
benzodiazepines and antipsychotic medication)
that could interfere with REE was a reason for
exclusion. For COPD patients, allowable drugs were
beta 2 agonists, inhaled corticosteroids and antic-
holinergic agents.
The study design was approved by the local
Ethical Committee. Patients were fully informed as
to the nature and purpose of the study and gave
their informed consent.
All subjects took several tests on the same
morning, as follows:
Biochemical analyses: Blood samples were ob-
tained in the morning after a 12-h overnight fast;
routine biochemical analyses included hemo-
chrome, urea, electrolytes, liver and kidney func-
tion indices, thyroid-stimulating hormone levels,
and erythrocyte sedimentation rate (ESR). The
blood was also analyzed for albumin, prealbumin
and retinol-binding protein (RBP).
Pulmonary function tests: Lung function was
evaluated using a computerized water-sealed
Stead-Wells spirometer (BAIRES System, Biomedin,
Padua, Italy), which meets the 1994 ATS recom-
mendations for diagnostic spirometry. The custo-
mized software assists the operator during the test
and enables on-line compliance monitoring accord-
ing to ATS criteria by displaying all parameters
relevant to the start and end of the test, as well as
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those relevant to the reproducibility of the FEV1
and FVC15 recordings.
An arterial blood sample was drawn from the
radial artery for blood gas analysis of PaO2 and
PaCO2 (ABL 300 blood gas analyzer, Radiometer,
Copenhagen, Denmark).
Physical performance: This was evaluated on the
basis of the distance covered during a 6-min
walking test (6MWT) according to Guyatt et al.16
Patients were asked to walk as far as possible in
6min in a hospital corridor 100m long. They could
set their own pace, stopping if necessary, and they
were told that at the end they should feel as though
they could not have walked any further. No
encouragement was given during the test. Since
learning effects have been known to occur quickly
with repeated walking tests, the patients per-
formed one practice 6MWT 30min prior to the
test.16
Anthropometry: Body weight was measured
to the nearest 0.1 kg and height was determined
to the nearest 0.1 cm with a standard balance
and stadiometer (Seca; Germany) with subjects
wearing light clothing and no shoes. Body mass
index (BMI) was calculated as the weight in
kilograms divided by the height in meters
squared.
Body composition: FFM and fat mass (FM) were
obtained by Dual Energy X-ray Absorptiometry
(DEXA) with fan-beam technology (Hologic QDR
4500 W, Inc). A standardized procedure was used
for positioning the patient and using the QDR
software. The DEXA scans were analyzed with the
Hologic software for body composition assessment,
rel. 8.21. DEXA has a good reproducibility in
determining soft tissue composition and a good
agreement has been found in elderly subjects.17
FFM and FM were expressed as absolute values, as a
percentage of body weight, and adjusted for height
squared as the FFM index (FFMI) and FM index (FMI).
Appendicular skeletal muscle mass (ASMM) was also
measured as the sum of the fat-free soft tissue
masses of the arms and legs, as described by
Heymsfield et al.18 Finally, the ASMM index (ASMMI)
was calculated as the ASMM divided by height
squared.10 As a cut-off for defining sarcopenia, we
used two standard deviations below the sex-specific
ASMMI mean values of the Rosetta Study on young
adults (7.26 for males), as proposed by Baumgart-
ner et al.10
Resting energy expenditure: REE was measured
with an open-circuit indirect calorimeter (Sensor
Medics Vmax-229 Metabolic System, CA) and a
ventilated hood system.
The patients arrived to the Department in the
early morning and lay supine for 30min before
beginning the test. The measurements were
taken after an overnight fast, under standardized
conditions, with the person lying awake and
emotionally undisturbed, completely at rest,
comfortably supine on a bed, their head under
a transparent ventilated canopy, in a thermally
neutral environment, and after at least 8 h of
sleep. Respiratory gas samples were taken
minute by minute for 30–40min and only measure-
ments from steady states were considered for the
analysis. Steady states were defined as time
intervals of at least 5min, during which every
average minute of oxygen consumption and
carbon dioxide production changed by less than
10%, and the average respiratory quotient changed
by less than 5%.
The calorimeter was calibrated each day before
the tests using a two-point calibration method
based on two separate mixtures of known gas
content. Carbon dioxide and oxygen concentra-
tions were compared with span gas (with known
oxygen and carbon dioxide fractions) and pure
nitrogen (as the zero level gas). Flow rate was
calibrated with a 3-L syringe, according to the
manufacturer’s instructions. The accuracy of the
system was tested regularly, twice a month, by
repeated measures of acetone combustion and
showed a good accuracy (2.4% error) and precision
(CV 0 1.5%).
The energy expenditure was calculated
from the VO2 and VCO2 in the stationary states
of the recording using the abbreviated Weir
equation.19
Statistical analysis: Data were analyzed using
Systat statistical software, rel. 8.01 for Windows
(SPSS Inc., Chicago). The results were expressed as
means7 the standard deviation. Differences in the
variables between COPD and healthy subjects were
evaluated using Student’s unpaired two-sided
t-test. Differences between prevalences were
tested by the w2 test. REE was normalized for FFM
variations in COPD and healthy subjects by analysis
of covariance, as suggested by previous Authors.20
The level of statistical significance for each test
was set at Po0.05.
REE was also predicted using an unpublished
formula generated in a sample of 100 local healthy
elderly subjects, using the same methods to
measure REE (indirect calorimetry) and FFM
(DEXA).
Patients were considered hypermetabolic when
the measured REE was more than 110% of the
predicted REE.8 The measured/predicted REE ratio
(REEm/REEp) was correlated with FEV1, FEV1%
predicted, FEV1/FVC ratio and 6MWT by simple
regression analysis.
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Results
Spirometric and blood gas values for the COPD
patients and normal subjects are given in Table 1.
As expected, the spirometric values (FEV1,
FEV1%pred, FEV1/FVC%) were significantly lower in
COPD subjects than in controls, the former being
more hypoxemic and hypercapnic. ESR (42.5724.1
vs 38.4722.4mm/h) and leukocyte (6.6972.0 vs
6.2671.88 103/mL) mean values did not differ
significantly in COPD and healthy subjects.
Nutritional and body composition parameters are
shown in Table 2. Age and anthropometric indexes
are similar in the two groups. The elderly COPD
subjects had similar mean BMI values, but a lower
FFM both in kg (50.776.3 vs 53.976.9 kg; Po0.05)
and after correction for height squared (18.072.0
vs 19.071.9; Po0.05). The mean ASMM and ASMMI
values were similar in patients and controls. The
prevalence of sarcopenia was 38% among COPD
subjects and 31% in the healthy group (P: ns).
Among the visceral proteins, mean albumin,
prealbumin and RBP values were lower in patients
than in controls, but the difference was only
statistically significant for albumin (38.275.4 vs
40.875.6 g/L; Po0.05). The prevalence of hypoal-
buminemia (o35 g/L) was 30% in COPD and 22% in
healthy subjects (P: ns).
Unadjusted mean REE values (17747334 vs
15707272 kcal/24 h; Po0.01) were significantly
higher in COPD patients than healthy subjects,
even after adjusting for FFM using the covariance
method (17727193 vs 16237212 kcal/24 h;
Po0.01) (Table 3) or expressed per kg of body
weight (24.974.1 vs 22.973.4 kcal/day/kg;
Po0.05).
Hypermetabolism, considered as a measured
REE4110% of the predicted REE,8 was seen in 60%
of COPD cases and 13.7% of healthy subjects
(Po0.01).
In the hypermetabolic COPD subgroup, REEm/
REEp ratio (REEm/REEp) correlated inversely with
6MWT (r:0.57; Po0.01) (Fig. 1), whereas no
relationship was found in the non-hypermetabolic
COPD subgroup (r: 0.08; P: ns) or the control group
(r: 0.20; P: ns).
Nor was any relationship found in the COPD
patients between REEm/REEp and spirometric in-
dices of lung function as FEV1 (Fig. 2), FEV1%
predicted (r0.09; P: ns), and FEV1/FVC ratio
(r0.12; P: ns).
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Table 1 Spirometric, blood gas analytical para-
meters and 6-min walking test (6MWT) in COPD
patients and controls. Values are presented as
mean (SD).
COPD
patients
(n ¼ 40)
Controls
(n ¼ 46)
PaO2 (mmHg) 75.0 (13.1) ** 95.3 (13.1)
PaCO2 (mmHg) 41.6 (5.2) * 37.1 (5.5)
pH 7.4 (0.039) 7.4 (0.055)
FEV1 (L) 1.3 (0.5) ** 2.8 (0.6)
FEV1% predicted 52.6 (17.5) ** 103.2 (17.8)
FEV1/FVC% 48.8 (9.8) ** 73.4 (9.0)
6MWT (m) 286.0 (76.2) * 405.4 (77.7)
COPD vs controls (*Po0.05,**Po0.01).
Table 2 Age, anthropometric and body composi-
tion indices for COPD patients and controls. Values
are presented as mean (SD).
COPD (n ¼ 40) Controls
(n ¼ 46)
Age 75.7 (5.3) 77.7 (7.0)
Height (cm) 167.8 (6.8) 168.0 (6.3)
Weight (kg) 71.9 (12.2) 71.3 (10.7)
BMI (kg/m2) 25.5 (3.6) 25.2 (3.2)
FFM (kg) 50.7 (6.3) * 53.9 (6.9)
FM (kg) 18.1 (6.2) 16.4 (5.6)
FFMI 18.0 (2.0) * 19.0 (1.9)
FMI 6.4 (2.0) 5.8 (1.9)
ASMM 20.9 (3.2) 21.5 (3.5)
ASMMI 7.39 (0.9) 7.55 (1.0)
Albumin 38.2 (5.4) * 40.8 (5.6)
Prealbumin 277.0 (62.9) 294.2 (90.5)
RBP 47.6 (12.7) 50.2 (17.6)
COPD vs Controls (*Po0.05). FFM: fat-free mass; FM: fat
mass; ASMM: appendicular skeletal muscle mass; FFMI:
FFM index; FMI: FM index; ASMMI: ASMM index; RBP:
retinol-binding protein.
Table 3 Resting energy expenditure (REE) in
COPD patients and controls. Values are presented
as mean (SD).
COPD
patients
(n ¼ 40)
Controls
(n ¼ 46)
Measured REE (Kcal/day) 1774
(334)**
1570
(272)
yAdjusted REE (Kcal/day) 1772
(193)**
1623
(212)
yyREE-BW (Kcal/day) 24.9
(4.1)*
22.9
(3.4)
COPD vs Controls (*Po0.05,**Po0.01).
yREE adjusted for FFM using covariance method
yyREE expressed per kilogram of body weight
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Discussion
This study investigated nutritional status, body
composition and REE in normal-weight or over-
weight elderly COPD patients to identify any early
conditions of hypermetabolism, sarcopenia and
malnutrition.
Our sample of COPD cases was small because we
adopted strict selection criteria to rule out other
factors that might interfere with nutritional status
and REE. The groups of healthy elderly subjects and
COPD patients were similar in terms of age, weight,
height and BMI, so any differences between their
nutritional parameters can be attributed to the
COPD rather than to any other factors.
As expected, our COPD patients fared signifi-
cantly less well in the pulmonary function tests and
blood gas parameters than the healthy controls,
though their mean PaO2 and PaCO2 were still
acceptable for elderly people. This may be due to
the fact that patients unable to perform the 6MWT
were ruled out.
COPD patients are known to be generally thin,
underweight, with a reduced FFM.21 Previous
studies on moderate or severe COPD showed that
FFM loss affected 20% of outpatients and 35% of
those eligible for pulmonary rehabilitation.22
Though their mean anthropometric values were
similar to those of the healthy group, our elderly
COPD patients had a significantly lower FFM in kg
and after correction for height squared (FFMI).
Several studies have already shown that age-
related FFM loss particularly involves peripheral
skeletal muscle and gives rise to weakness.10 This
process, called sarcopenia, is being recognized as a
major cause of disability and mortality in the
elderly population.23 Indeed, 30% of our healthy
elderly people were sarcopenic using Baumgartner
criteria.10 Though sarcopenia is part of the normal
aging process, muscle wasting is accelerated by
chronic diseases. COPD accelerates muscle loss,
particularly in the acute phase, due to higher levels
of circulating proinflammatory cytokines (IL1, TNF,
IL6) prompting an increase in protein turnover,
hypoxemia and acidosis, and further restricting
physical activity.24
In our study, the mean ASMM and ASMMI values
used to define sarcopenia were not statistically
different between the control and COPD groups.
The prevalence of sarcopenia was only 7% greater
in the COPD patients than in controls. ASMMI only
evaluates the muscle mass of limbs and probably
underestimates sarcopenia in cases of COPD, whose
chest muscle mass may also be affected.25 On the
basis of our results, we can nonetheless assume
that it is difficult to detect COPD-attributable
muscle wasting in elderly COPD patients because
loss of FFM only occurs in a minority of outpatients
with COPD and older patients lose muscle anyway
as part of the aging process.
Our elderly COPD patients had lower mean
albumin values than controls. These results are
consistent with those reported in previous stu-
dies26,27 where hypoalbuminemia was prevalent in
COPD. The lower mean albumin values may be due
to malnutrition and/or chronic inflammation.28 Our
patients had slightly, but not significantly higher
values for ESR and leukocytes, adding support to
the clinical impression that their COPD was stable.
Unfortunately, more specific markers of inflam-
mation, such as high-sensitivity CRP, IL1–IL6, etc.,
were not measured in our patients, so it is hard to
pinpoint the cause of their mild hypoalbuminemia
to a worse nutritional status or chronic inflamma-
tion.
Previous studies have already demonstrated that
a low dietary energy intake is certainly a problem
in COPD, and particularly in the more severe
cases.8 Malnourished subjects suffer more from
anorexia, early satiety, dyspnea and dry mouth,4
and medication plays an important part.
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Figure. 1 Relationship between REE measured/REE pre-
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in the hypermetabolic COPD subgroup.
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Another reason for a negative energy balance in
COPD patients is the increase in REE, affecting
about one third of adult patients. As already
confirmed in younger patients, COPD causes several
metabolic adjustments that lead to an increased
metabolic activity to ensure adequate ventila-
tion.29 Moreover, the drugs used to treat COPD
(beta 2 agonists, corticosteroids and theophylline)
also increase REE.30
Our study shows that 60% of elderly COPD had
associated hypermetabolism, while only about one
third of them had low albumin and sarcopenia. This
might suggest that hypermetabolism in elderly
COPD subjects precedes nutritional decline and
contributes to malnutrition and FFM and muscle
mass loss.
The prevalence of hypermetabolism was greater
among our COPD patients than in other studies. Two
reports on COPD patients who were 10 years
younger on average found the prevalence of
hypermetabolism to be 26%8 and 34%.9 Schools
reports that hypermetabolism is overestimated
when REE is predicted using equations (Harris
Benedict) that consider only anthropometric in-
dices rather than FFM. For this reason, to predict
REE we used a formula derived from a linear
regression of REE on FFM generated in a healthy
elderly population. Our COPD cases were probably
more hypermetabolic for different reasons. It is
feasible to suggest that REE increases particularly
in old people with COPD to guarantee respiratory
function despite a lower muscle mass. But these
differences can be due to the different methods
used to estimate body composition. In previous
investigations, FFM was determined by bioelectri-
cal impedance analysis (BIA), which is less reliable
than DEXA in assessing body composition.31,32
Conversely, we believe that our results under-
estimate hypermetabolism in elderly COPD because
our study ruled out patients with other conditions
that raise REE (multiple comorbidities, acute
exacerbation of disease and oral or systemic intake
of corticosteroids or theophylline).
Hypermetabolism seems to be independent of
the severity of COPD, since no correlation was
found between the ratio of measured/predicted
REE and lung obstruction parameters such as FEV1
and FEV1/FVC ratio. These results are consistent
with other studies, where FEV1 was higher in
hypermetabolic than in normometabolic COPD.9
Unfortunately, the investigation on the relationship
between hypermetabolism and lung performance is
limited because indices of lung function, other than
spirometry, were not measured.
Hypermetabolism, however, has a negative fall-
out on physical performance in any case. In our
subgroup of hypermetabolic COPD cases, the
measured/predicted REE ratio correlated inversely
with the walking test results and accounted for
more than 30% of the variability in the distance
covered. The physical performance of elderly COPD
patients seems to depend on numerous factors,
among which hypermetabolism can have an im-
portant role, but it is difficult to grasp the
foundations for this relationship and further studies
are needed to confirm and clarify it.
In conclusion, our study demonstrates that
elderly patients with stable COPD have an in-
creased resting metabolic rate. This hypermetabo-
lism seems to be independent of the severity of the
pulmonary obstruction and to influence the pa-
tient’s physical performance.
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